Factors associated with success at COVID- 19 vaccination sites in South Africa
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i11.16794Keywords:
COVID-19, vaccination sitesAbstract
-
References
Goga A, Bekker L, Garrett N, et al. Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics. S Afr Med J 2022;112(5b):375-383. https://doi. org/10.7196/SAMJ.2022.v112i5b.16098
National Department of Health, South Africa. Latest vaccine statistics. Pretoria: NDoH, 2022. https:// sacoronavirus.co.za/latest-vaccine-statistics/ (accessed 12 August 2022).
Govere-Hwenje S, Jarolimova J, Yan J, et al. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community. BMC Public Health 2022;22(1):1239. https://doi.org/10.1186/s12889-022-13623-w
Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: How can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines 2021;20(8):921-933. https://doi.org/10. 1080/14760584.2021.1949291
Statistics South Africa. Mid-year population estimates. Pretoria: StatsSA, 2022. https://www.statssa. gov.za/publications/P0302/P03022022.pdf (accessed 12 August 2022).
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
